Greenwich Lifesciences Inc (GLSI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Operating Expenses | 9,710 | 2,729 | 2,661 | 2,537 | 2,836 |
| Operating Income | -9,710 | -2,729 | -2,661 | -2,537 | -2,836 |
| Other Income | 44 | 60 | 55 | 64 | 89 |
| Pre-tax Income | -9,666 | -2,669 | -2,607 | -2,473 | -2,747 |
| Net Income Continuous | -9,666 | -2,669 | -2,607 | -2,473 | -2,747 |
| Net Income | $-9,666 | $-2,669 | $-2,607 | $-2,473 | $-2,747 |
| EPS Basic Total Ops | -0.75 | -0.20 | -0.20 | -0.19 | -0.20 |
| EPS Basic Continuous Ops | -0.74 | -0.20 | -0.20 | -0.19 | -0.21 |
| EPS Diluted Total Ops | -0.75 | -0.20 | -0.20 | -0.19 | -0.20 |
| EPS Diluted Continuous Ops | -0.74 | -0.20 | -0.20 | -0.19 | -0.21 |
| EPS Diluted Before Non-Recurring Items | -0.61 | -0.20 | -0.20 | N/A | N/A |
| EBITDA(a) | $-9,709 | $-2,728 | $-2,661 | $-2,536 | $-2,835 |